Abstract
This issue of Workplace Health & Safety contains a Continuing Nursing Education Module for 1.0 contact hour of continuing nursing education credit will be awarded by AAOHN upon successful completion of the posttest and evaluation.
A certificate will be awarded when the following requirements are met by the participant: (1) Participant logs on to the AAOHN LMS website at www.aaohn.org/education/online-learning-center and enrolls in the course ($10 members; $15 non-members); (2) The completed posttest and course evaluation are entered online at http://www.aaohn.org by December 2023; (3) A score of 75% (6 correct answers) is achieved by the participant.
Upon completion of this lesson, the occupational health nurse will be able to:
Identify the most common adverse events associated with the use of medicinal cannabis.
Describe how adverse events related to the use of medicinal cannabis may affect the workplace.
List individual characteristics which may result in differing responses and adverse events in users of medicinal cannabis.
The American Association of Occupational Health Nurses, Inc. is an Approved Provider of continuing nursing education by the American Association of Occupational Health Nurses, Inc., an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. The American Association of Occupational Health Nurses, Inc. is additionally approved as a CNE provider by the California Board of Registered Nursing (#CEP9283).
Contact hours received for successful completion of the posttest and evaluation may be used for relicensure, certification, and re-certification.
According to MacCallum et al. (2018): a. Medicinal use of cannabis does not result in patient safety issues. b. There is a dearth of high-quality, long-term studies to clarify patient safety issues related to medicinal use of cannabis. c. The Federal Drug Administration equates medicinal use of cannabis to quackery. d. Many high-quality studies suggest medicinal cannabis is safe and effective.
The rates and type of adverse events due to medicinal use of cannabis differ based on: a. The time of day the drug is administered. b. The route of administration. c. Age, underlying health conditions, gender, and weight. d. Patient compliance; interaction with other medications, food, or vitamins; and overall health. e. c. and d. f. All the above.
In this scoping review of systematic reviews: a. Each study was evaluated and given a quality score. b. Only systematic reviews and meta-analysis studies were included. c. There was a limited literature search, and some important studies could have been missed. d. There was an exhaustive literature search including studies going back over 20 years.
The most commonly reported adverse events due to medicinal cannabis included: a. Memory loss, hallucinations, and dizziness. b. Gynomastia, suicidal thoughts, and depression. c. Sedation, nausea and vomiting, dizziness, and euphoria. d. None of the above.
Medicinal cannabis users may experience transient psychosis and dependence due to: a. The practice of intramuscular injection. b. More frequent use in patients with hypochondriacal tendencies. c. The delayed onset of action when the medicinal cannabis is consumed in baked goods. d. Increased tolerance to the drug leading to behavioral and mood symptoms of withdrawal.
Cannabis can lead to clinical impairment of: a. Psychological, cognitive, and physiological functioning. b. Skill in performing mathematical calculations. c. Female sex drive and reproductive success. d. None of the above.
Medicinal cannabis has the potential to affect workplace health and safety due to: a. Decreased alertness and reaction times. b. Reduced ability to drive and operate machinery. c. Increased absenteeism and increased risk of falling. d. All the above. e. None of the above.
True or False: There is a globally accepted definition of impairment associated with medicinal cannabis use and agreement on how to measure its occurrence.
In a National Institute on Drug Abuse study, workers who tested positive for cannabis: a. Had 75% higher absenteeism and 85% more injuries. b. Were no more likely to experience an industrial accident than workers who tested negative. c. Were more likely to have an altercation with other employees. d. Were more productive because their chronic pain was minimized by cannabis.
The principal aim of all 31 studies analyzed in this scoping review was to: a. Determine whether serious adverse events were temporally related to medicinal cannabis use. b. Define what blood level of tetrahydrocannabinol would be most likely to result in impaired reaction time, motor coordination, and ability to judge. c. Review the efficacy and safety aspects of medicinal cannabis across a range of disorders. d. None of the above.